Working Paper 2 -  Site selection - Financial Considerations

 

Financial Considerations figure in option appraisal in two ways, value for money and affordability.  Both have elements of subjectivity and our current thoughts are set out below.

 

Value for Money is the test we will seek to apply to which mix of sites to use to create the LCH/CCH network. The perspective is that of an NHS Trust and their income and expenditure account.

 

Affordability is the test we will seek to apply to whether the LCH/CCH network is able to be afforded by the NHS.  The perspective is that of a Primary Care Trust, and their funding stream.

 

Value for Money

Assessment of value for money is made by assessing benefits against cost. Assessing the options against the criteria produces a view of how each option ranks in terms of producing a benefit.  The choice of which one to select as the preferred, value for money, option then has to bring cost into the equation.

 

It may be that the choice is to select the highest benefit option regardless of cost.  But it may be that the second best set of benefits is only marginally inferior to the best - but is a lot cheaper, and is therefore best value for money.

 

In terms of our NHS appraisal of sites, we will be seeking to establish the relative capital cost of each option, and judge it against the benefits of each option.

 

Any difference in capital costs will have an impact on the revenue costs, since the LCH/CCH network will have to pay capital charges.

 

Most of the other revenue costs will, however, be assumed to be neutral as between sites.  Staffing costs, drugs and medical equipment, food, cleaning, maintenance etc are costs which are likely to vary with the number of cases treated or the size of the facility, regardless of where it is located.

 

Affordability

 

The overall affordability of the LCH/CCH concept was set out in the Strategic Outline Case.  It will need to be reworked for the Outline Business Case - partly as a matter of course (each stage in the Business Case process requires more detail) but partly because of changes in the policy context.

 

The following paragraphs are to share our thinking on the issues involved:

 

1.      How much more work will have to be undertaken by the new network of LCHs supported by one CCH?

The Strategic Outline Case estimated by 2010 about 15% more work overall.  We need to check these projections for reasonableness in the light of demographics and the NHS Plan targets for waiting lists - plus also our own target to keep people out of hospital.

 

2.      What is the income of the new network of LCH/CCH?

Under a new system of Payment by Results, to be introduced in 2005, the income of LCH/CCH network will  be the cases it treats multiplied by a nationally fixed price per case.  Thus the income is no longer a matter of negotiation with Primary Care Trusts, and realistic forecasts of activity are key.  15% more activity brings 15% more income.

 

3.      What will the cost be of the new network of LCH/CCH?

Because of the new 'payment by results’ regime, the cost base of the new network will have to be constrained to the income levels forecast in steps 1 and 2 above.  The decision for the managers/planners is how to configure services to live within that income.

 

The SOC was predicated on the fact that staffing is an increasingly scarce resource in the UK (and indeed, there is global competition for healthcare workers).  Taken together with increasingly stringent rules on shift working, and junior doctor training, it was not sensible to assume that a 15% rise in caseload should be matched by a 15% rise in staffing in the same hospital configuration.

 

Instead the SOC models a modest increase in staffing levels using the extra funding from extra caseload to pay for extra capital charges (which in their turn pay for extra capital spending on new buildings in new settings to work more efficiently).

 

4.      Does that mean the reconfiguration is affordable?

If these calculations are correct, then the CCH/LCH network is financially viable - i.e. its income can meet its expenditure.  The calculations do need to be re-worked for the Outline Business Case since they will be scrutinised by DoH officials and potentially HM Treasury.

 

In particular at this stage of the Business Case process, what needs to be explored is the relative cost of each site option.  As long as the extra caseload can be achieved, site selection which minimises capital spend is to be preferred to more expensive solutions - since this would reduce expenditure from capital charges without reducing income, and thus create a greater margin of safety in the calculation of financial viability.

 

5.             But can the NHS afford the total extra expense?

That is a different sort of affordability.  Prior to the new financial regime, the Primary Care Trusts were required to give their agreement to Business Cases - exercising a judgement about whether they could afford any extra expense (e.g. in Acute Care) in relation to the other demands on their budget (e.g. Primary Care, Mental Health).

 

         Under the Payment by Results regime, that choice will not be open to them.  If 15% more acute work is done - whether in a new LCH/CCH network or the old Epsom/St Helier reconfiguration - they will have to pay for it.

 

Since they can't negotiate what they pay per case, they can only reduce their total spend by reducing the number of cases that progress to acute hospitals.

 

6.             Should we build for 15% more patients?

 

The earlier analysis raises two important questions:

 

·         Which option is likely to give the best chance of controlling the volume of patients entering hospital for treatment?

 

·         If the volume of patients treated does not rise by 15% where does this leave the financial viability of the LCH/CCH?

 

The current view of the NHS is that a LCH/CCH network is more likely than the current hospital configuration to offer PCTs the ability to control the volume of patients entering hospital for treatment and the length of time they stay when they are there.  This is because the LCH network of outpatients and diagnostics closely interlinked with Primary Care is designed to move patients appropriately through the system.

 

If the LCH/CCH does exercise control and as result the volume of patients did not rise by 15%, then the income of the LCH/CCH would be less: but the size of facilities which would need to be built would be less (and so in consequence would capital cost and the revenue impact from capital charges).

 

         There is a further policy initiative which alters the historic ground rules.  Again from 2005, patients will be able to exercise choice.  This will be over many dimensions of care, but in the context of the present appraisal the dimensions that matter will be their choice of hospital.

 

         So, we are building for a future where either more or less than the current patients of Epsom/St Helier might choose to use the new LCH/CCH configuration.

 

Alternative scenarios of the financial viability need to be modelled.

 

 

 

Conclusion

Our intention at this stage  is to concentrate on establishing the financial factors which would be influential in choosing between sites for a Critical Care Hospital using consistent assumptions.

 

But these assumptions need to be explored in the OBC – so we decide what size to make the new LCH/CCH network (or perhaps, how to create the flexibility to keep the options of  size open as we see how the 2005 policy unfold as regards patient choice and payment by results).